The Boston Globe’s medicine and health news site Stat is introducing a $299-a-year premium plan for professionals working in and around the pharma and biotech industries, reports Lucia Moses of Digiday.
Moses writes, “At launch, Stat Plus benefits will include a daily newsletter by Stat’s star pharma columnist Ed Silverman; exclusive and early looks at pharma and biotech coverage; a private Slack channel for subscribers and chats with Stat writers covering those industries, as well as exclusive invitations to events. Stat counts the size of the target market in the hundreds of thousands, and is aiming for at least 10,000 of them to sign up.
“It’s a fast timetable. Politico, the fast-paced political news site whose model Stat is loosely based on, was four years in before it launched its membership model Politico Pro, and it did so with 40 people, a team the same size as its newsroom. Politico Pro starts at $5,000 a year and can exceed $100,000, depending on the level of subscription.
“Stat is only one year old, and its cost puts it more in The New York Times camp than Politico’s, but it’s also putting fewer resources behind it. The publication has a full-time staff of 50 and is putting a ‘handful’ of business- and edit side people on Stat Plus, but not all of them will be dedicated full-time to it.”
Read more here.
